This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Filleur, S. Articles by Volpert, O. V. Search for Related Content PubMed PubMed Citation Articles by Filleur, S. Articles by Volpert, O. V.

Two Functional Epitopes of Pigment Epithelial–Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer

Departments of ¹ Urology and ² Surgery, and RH Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University; ³ Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, Illinois; ⁴ Department of Urology, Otto-von-Guericke-University Magdeburg, Leipziger, Magdeburg, Germany; and ⁵ Section of Protein Structure-Function, Laboratory of Retinal Cell and Molecular Biology, NEI-NIH, Bethesda, Maryland

Requests for reprints: Olga Volpert, Department of Urology, Feinberg School of Medicine, Northwestern University, Tarry Research Building, Ste. 16-761, 300 East Superior Street, Chicago, IL 60611. Phone: 312-503-5934; Fax: 312-908-7275; E-mail: olgavolp{at}northwestern.edu.

Pigment epithelial-derived factor (PEDF), an angiogenesis inhibitor with neurotrophic properties, balances angiogenesis in the eye and blocks tumor progression. Its neurotrophic function and the ability to block vascular leakage is replicated by the PEDF 44-mer peptide (residues 58-101). We analyzed PEDFs' three-dimensional structure and identified a potential receptor-binding surface. Seeking PEDF-based antiangiogenic agents we generated and tested peptides representing the middle and lower regions of this surface. We identified previously unknown antiangiogenic epitopes consisting of the 34-mer (residues 24-57) and a shorter proximal peptide (TGA, residues 16-26) with the critical stretch L₁₉VEEED₂₄ and a fragment within the 44-mer (ERT, residues 78-94), which retained neurotrophic activity. The 34-mer and TGA, but not the 44-mer reproduced PEDF angioinhibitory signals hinged on c-jun-NH₂-kinase–dependent nuclear factor of activated T cell deactivation and caused apoptosis. Conversely, the ERT, but not the 34-mer/TGA induced neuronal differentiation. For the 44-mer/ERT, we showed a novel ability to cause neuroendocrine differentiation in prostate cancer cells. PEDF and the peptides bound endothelial and PC-3 prostate cancer cells. Bound peptides were displaced by PEDF, but not by each other, suggesting multiple receptors. PEDF and its active fragments blocked tumor formation when conditionally expressed by PC-3 cells. The 34- and 44-mer used distinct mechanisms: the 34-mer acted on endothelial cells, blocked angiogenesis, and induced apoptosis whereas 44-mer prompted neuroendocrine differentiation in cancer cells. Our results map active regions for the two PEDF functions, signaling via distinct receptors, identify candidate peptides, and provide their mechanism of action for future development of PEDF-based tumor therapies.

This article has been cited by other articles:

				R. Bass, L. Wagstaff, L. Ravenhill, and V. Ellis Binding of Extracellular Maspin to {beta}1 Integrins Inhibits Vascular Smooth Muscle Cell Migration J. Biol. Chem., October 2, 2009; 284(40): 27712 - 27720. [Abstract] [Full Text] [PDF]

				A. Bernard, J. Gao-Li, C.-A. Franco, T. Bouceba, A. Huet, and Z. Li Laminin Receptor Involvement in the Anti-angiogenic Activity of Pigment Epithelium-derived Factor J. Biol. Chem., April 17, 2009; 284(16): 10480 - 10490. [Abstract] [Full Text] [PDF]

				Y. Mirochnik, A. Aurora, F. T. Schulze-Hoepfner, A. Deabes, V. Shifrin, R. Beckmann, C. Polsky, and O. V. Volpert Short Pigment Epithelial-Derived Factor-Derived Peptide Inhibits Angiogenesis and Tumor Growth Clin. Cancer Res., March 1, 2009; 15(5): 1655 - 1663. [Abstract] [Full Text] [PDF]

				T.-C. Ho, S.-L. Chen, Y.-C. Yang, T.-H. Lo, J.-W. Hsieh, H.-C. Cheng, and Y.-P. Tsao Cytosolic phospholipase A2-{alpha} is an early apoptotic activator in PEDF-induced endothelial cell apoptosis Am J Physiol Cell Physiol, February 1, 2009; 296(2): C273 - C284. [Abstract] [Full Text] [PDF]

				S. P. Becerra, L. A. Perez-Mediavilla, J. E. Weldon, S. Locatelli-Hoops, P. Senanayake, L. Notari, V. Notario, and J. G. Hollyfield Pigment Epithelium-derived Factor Binds to Hyaluronan: MAPPING OF A HYALURONAN BINDING SITE J. Biol. Chem., November 28, 2008; 283(48): 33310 - 33320. [Abstract] [Full Text] [PDF]

				E. D. Karagiannis and A. S. Popel A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells PNAS, September 16, 2008; 105(37): 13775 - 13780. [Abstract] [Full Text] [PDF]

				T.-C. Ho, S.-L. Chen, Y.-C. Yang, C.-L. Liao, H.-C. Cheng, and Y.-P. Tsao PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells Cardiovasc Res, November 1, 2007; 76(2): 213 - 223. [Abstract] [Full Text] [PDF]

				C.R. Dass, T.M.N. Tran, and P.F.M. Choong Angiogenesis Inhibitors and the Need for Anti-angiogenic Therapeutics Journal of Dental Research, October 1, 2007; 86(10): 927 - 936. [Abstract] [Full Text] [PDF]

				L. Notari, V. Baladron, J. D. Aroca-Aguilar, N. Balko, R. Heredia, C. Meyer, P. M. Notario, S. Saravanamuthu, M.-L. Nueda, F. Sanchez-Sanchez, et al. Identification of a Lipase-linked Cell Membrane Receptor for Pigment Epithelium-derived Factor J. Biol. Chem., December 8, 2006; 281(49): 38022 - 38037. [Abstract] [Full Text] [PDF]

				E. T.H. Ek, C. R. Dass, and P. F.M. Choong Pigment epithelium-derived factor: a multimodal tumor inhibitor. Mol. Cancer Ther., July 1, 2006; 5(7): 1641 - 1646. [Abstract] [Full Text] [PDF]

				G. Maik-Rachline and R. Seger Variable phosphorylation states of pigment-epithelium-derived factor differentially regulate its function Blood, April 1, 2006; 107(7): 2745 - 2752. [Abstract] [Full Text] [PDF]

				P. A. Campochiaro and the First ARVO/Pfizer Institute Working Group Ocular versus Extraocular Neovascularization: Mirror Images or Vague Resemblances Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 462 - 474. [Full Text] [PDF]